Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an 'option' but an ethical obligation

被引：12

作者：

Brandao, Mariana ^{[1
]}

Reyal, Fabien ^{[2
,3
]}

Hamy, Anne-Sophie ^{[3
]}

Piccart-Gebhart, Martine ^{[1
]}

机构：

[1] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium

[2] PSL Res Univ, Residual Tumor & Response Treatment Lab, Paris, France

[3] Inst Curie, Breast & Gynecol Canc & Reconstruct Surg Team, Paris, France

来源：

ESMO OPEN | 2019年 / 4卷 / 03期

关键词：

DE-ESCALATION STRATEGIES; PREDICTIVE MARKERS; ENDOCRINE THERAPY; TRIAL-EFFICACY; FINAL ANALYSIS; TRASTUZUMAB; CHEMOTHERAPY; SAFETY;

D O I：

10.1136/esmoopen-2019-000515

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 25 条

[1] Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials [J].

Alberro, J. A. ;

Ballester, B. ;

Deulofeu, P. ;

Fabregas, R. ;

Fraile, M. ;

Gubern, J. M. ;

Janer, J. ;

Moral, A. ;

de Pablo, J. L. ;

Penalva, G. ;

Puig, P. ;

Ramos, M. ;

Rojo, R. ;

Santesteban, P. ;

Serra, C. ;

Sola, M. ;

Solarnau, L. ;

Solsona, J. ;

Veloso, E. ;

Vidal, S. ;

Abe, O. ;

Abe, R. ;

Enomoto, K. ;

Kikuchi, K. ;

Koyama, H. ;

Masuda, H. ;

Nomura, Y. ;

Ohashi, Y. ;

Sakai, K. ;

Sugimachi, K. ;

Toi, M. ;

Tominaga, T. ;

Uchino, J. ;

Yoshida, M. ;

Coles, C. E. ;

Haybittle, J. L. ;

Moebus, V. ;

Leonard, C. F. ;

Calais, G. ;

Garaud, P. ;

Collett, V. ;

Davies, C. ;

Delmestri, A. ;

Sayer, J. ;

Harvey, V. J. ;

Holdaway, I. M. ;

Kay, R. G. ;

Mason, B. H. ;

Forbe, J. F. ;

Franci, P. A. .

LANCET ONCOLOGY, 2018, 19 (01) :27-39

[2]

[Anonymous], BREAST CANC

[3]

[Anonymous], CANC RES

[4] Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].

Cortazar, Patricia ;

Zhang, Lijun ;

Untch, Michael ;

Mehta, Keyur ;

Costantino, Joseph P. ;

Wolmark, Norman ;

Bonnefoi, Herve ;

Cameron, David ;

Gianni, Luca ;

Valagussa, Pinuccia ;

Swain, Sandra M. ;

Prowell, Tatiana ;

Loibl, Sibylle ;

Wickerham, D. Lawrence ;

Bogaerts, Jan ;

Baselga, Jose ;

Perou, Charles ;

Blumenthal, Gideon ;

Blohmer, Jens ;

Mamounas, Eleftherios P. ;

Bergh, Jonas ;

Semiglazov, Vladimir ;

Justice, Robert ;

Eidtmann, Holger ;

Paik, Soonmyung ;

Piccart, Martine ;

Sridhara, Rajeshwari ;

Fasching, Peter A. ;

Slaets, Leen ;

Tang, Shenghui ;

Gerber, Bernd ;

Geyer, Charles E., Jr. ;

Pazdur, Richard ;

Ditsch, Nina ;

Rastogi, Priya ;

Eiermann, Wolfgang ;

von Minckwitz, Gunter .

LANCET, 2014, 384 (9938) :164-172

[5] Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update [J].

Denduluri, Neelima ;

Chavez-MacGregor, Mariana ;

Telli, Melinda L. ;

Eisen, Andrea ;

Graff, Stephanie L. ;

Hassett, Michael J. ;

Holloway, Jamie N. ;

Hurria, Arti ;

King, Tari A. ;

Lyman, Gary H. ;

Partridge, Ann H. ;

Somerfield, Mark R. ;

Trudeau, Maureen E. ;

Wolff, Antonio C. ;

Giordano, Sharon H. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (23) :2433-+

[6] Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics [J].

Ellis, Matthew J. ;

Tao, Yu ;

Luo, Jingqin ;

A'Hern, Roger ;

Evans, Dean B. ;

Bhatnagar, Ajay S. ;

Ross, Hilary A. Chaudri ;

von Kameke, Alexander ;

Miller, William R. ;

Smith, Ian ;

Eiermann, Wolfgang ;

Dowsett, Mitch .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (19) :1380-1388

[7]

Garcia-Murillas I., 2015, Sci Transl Med, V7, p302ra133

[8] 18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO [J].

Gebhart, Geraldine ;

Gamez, Cristina ;

Holmes, Eileen ;

Robles, Javier ;

Garcia, Camilo ;

Cortes, Montserrat ;

de Azambuja, Evandro ;

Fauria, Karine ;

Van Dooren, Veerle ;

Aktan, Gursel ;

Coccia-Portugal, Maria Antonia ;

Kim, Sung-Bae ;

Vuylsteke, Peter ;

Cure, Herve ;

Eidtmann, Holger ;

Baselga, Jose ;

Piccart, Martine ;

Flamen, Patrick ;

Di Cosimo, Serena .

JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) :1862-1868

[9] Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis [J].

Gu, Yan-Lin ;

Pan, Si-Meng ;

Ren, Jie ;

Yang, Zhi-Xue ;

Jiang, Guo-Qin .

CLINICAL BREAST CANCER, 2017, 17 (04) :245-255

[10] De-escalated therapy for HR+/HER2+breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study [J].

Guarneri, V ;

Dieci, M., V ;

Bisagni, G. ;

Frassoldati, A. ;

Bianchi, G., V ;

De Salvo, G. L. ;

Orvieto, E. ;

Urso, L. ;

Pascual, T. ;

Pare, L. ;

Galvan, P. ;

Ambroggi, M. ;

Giorgi, C. A. ;

Moretti, G. ;

Griguolo, G. ;

Vicini, R. ;

Prat, A. ;

Conte, P. F. .

ANNALS OF ONCOLOGY, 2019, 30 (06) :921-926

← 1 2 3 →